OverviewEMEA Medical Affairs Director, Evidence Strategy based in EMEA for Johnson & Johnson. This role leads the strategic evidence generation process across the lifecycle in the Janssen pipeline to support rapid, optimal market access and differentiation versus competitor medicines. The objective is to oversee a best-in-class end-to-end evidence generation strategy for EMEA on the Medical and Access aspects, evolving with the organization.Join us in developing treatments, finding cures, and championing patients every step of the way.We are looking for an EMEA Medical Affairs Director, Evidence Strategy, to be based in EMEA. The role reports directly to the ESO Medical Excellence Senior Director, EMEA Operational Excellence Strategy.ResponsibilitiesOversee best-in-class EMEA cross-TA evidence generation strategy.Establish a clear cross-TA process and operating model for:Evidence Generation short- to long-term plansEMEA Integrated Evidence Generation and Dissemination PlanLead regional IEGP process for the EMEA region:Train IBVT and CVT teams on responsibilities and key deliverablesOrganize and chair IEGP strategy (Q1) and IEGP tactics (Q2) reviewsEstablish prioritization for ESO EG investmentsPresent consolidated plans and seek endorsement from leadership bodies (ESLT, ELT)Coordinate EMEA contribution to the WW IEGP process:Align deliverables of EMEA and WW IEGP processesReview and provide recommendations to optimize WW IEGP impact for EMEAWork with VP MAF and VP HEMAR to agree and finalize the aboveOversee communication and rollout of EMEA plans involving key stakeholdersIdentify and collate with key stakeholders a core set of evidence deliverables and timelines that create value for EMEAIncorporate competitive insights cross-TA via CI tools (Insight Miner) with CDSDesign and track medical and business impact of EMEA IEGPEstablish collaboration model with EMEA HEMAR and MAF TA teams with clear rolesStrengthen engagement and processes with key countries to ensure their inputIdentify priorities for key countries and facilitate early engagement with global decision-makersIdentify opportunities to strengthen EMEA input into core processes such as early CDP shaping, TPP development, regulatory discussionsContinually assess the need for new capabilities or resources to support cross-TA evidence strategyContribute to company processes such as long-range financial planningEssential Knowledge & SkillsExtensive pharmaceutical background with regional perspective; ability to assimilate complex science and data quickly. A higher scientific degree (e.g., PhD or MD) is desired.Behaviors aligned to the J&J Global Leadership Profile: integrity, collaboration, urgency, results orientation, and people development.Travel up to 10%.Fluency in English required; additional EMEA languages are advantageous.ExperienceMinimum of 8 years of progressive Medical Affairs experience with proven leadership.Experience with R&D programs and development of commercial and evidence generation strategy.More than 5 years in teams generating Evidence Generation plans.More than 5 years in teams planning and executing Medical Education plans.The role is EMEA-based and may require extensive travel. Based in the country of residence with access to local JJIM offices as needed. The role may be posted across multiple countries to comply with local requirements.
#J-18808-Ljbffr